Research Library — Clinical Trials — Page 2 | Reta Compare
73 research articles in Clinical Trials. Page 2 of 3.
Articles
- Investigating Hypoglycemia Recovery in Type 2 Diabetes Patients Treated with Retatrutide
- Exploring the Role of Retatrutide in Muscle Preservation During GLP-1 Agonist Therapy
- Evaluating the Efficacy of Retatrutide in Type 2 Diabetes with Renal Impairment
- Investigating the Impact of Retatrutide on Renal Function in Obese Patients
- Exploring the Impact of Retatrutide on Caloric Intake and Energy Metabolism in Obesity
- Evaluating the Efficacy of Retatrutide in Obesity and Cardiovascular Disease
- Investigating the Impact of Retatrutide on Metoprolol Pharmacokinetics
- Evaluating the Efficacy and Safety of Retatrutide in Obesity Management
- Examining Retatrutide: Insights from a Study on Liver Function Impact
- Exploring Retatrutide: Insights from the LY3437943 Study on Healthy Participants
- Investigating Retatrutide's Impact on Hormonal Levels in Postmenopausal Women
- Investigating Retatrutide: A Study on Injection Device Similarity
- Investigating Retatrutide Pharmacokinetics in Renal Impairment: A Clinical Study Overview
- Exploring the Effects of Retatrutide on Weight Loss in Obesity and Overweight Participants
- Exploring the Safety and Tolerability of Retatrutide in Chinese Participants with Obesity
- Evaluating the Efficacy of Retatrutide in Type 2 Diabetes Management
- Exploring the Drug-Drug Interactions of Retatrutide: Insights from a New Study
- Advancements in Retatrutide Research: Surgical Threshold Crossed
- Retatrutide Shows Promising Results in Phase 3 Trial for Type 2 Diabetes Management
- Retatrutide Achieves Phase III Metabolic Targets in Recent Clinical Trials
- Retatrutide Demonstrates Efficacy in Reducing Glycated Hemoglobin and Body Weight
- Retatrutide Demonstrates Effective Glycemic Control and Weight Loss in Recent Phase 3 Trial
- Retatrutide Shows Promising Results in Phase 3 Trial for Type 2 Diabetes Management
- Retatrutide Shows Promising Efficacy in Phase 3 Trial for Type 2 Diabetes Management
- Retatrutide Advances in Late-Stage Diabetes Trial, Showing Promising Results